Approval · Notice of Compliance 32979 · 2024
ZOLMITRIPTAN: Notice of Compliance 32979
Issued March 28, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32979
- Date
- March 28, 2024
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Licensing Agreement Between Two Manufacturers
- Canadian reference product
- ZOMIG / ZOMIG RAPIMELT (Astrazeneca Canada Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZOLMITRIPTAN | 02546833 | Approved |
| ZOLMITRIPTAN ODT | 02546841 | Approved |
Medicinal ingredients
- ZOLMITRIPTAN 2.5 MG per TAB